| Banks Industry | Financials Sector | Dr. Andreas Wicki Ph.D. CEO | SIX Exchange | CH0012627250 ISIN |
| CH Country | - Employees | 2 Jul 2025 Last Dividend | - Last Split | - IPO Date |
HBM Healthcare Investments AG is a seasoned investor in the healthcare industry, focusing on a broad spectrum of investment opportunities within the sector. The company leverages a multifaceted strategy that includes both fund of funds and direct investments, targeting middle market and mature companies as well as emerging and small cap public entities. With an investment philosophy that spans the entire lifecycle of a company—from start-up phases to late-stage ventures and buyouts—HBM Healthcare Investments AG stands out for its dedication to fostering growth within the healthcare sector. The company's investment approach is global, with particular attention to Asia Pacific, Asia, North America, and Europe, underscoring its aim to capitalize on healthcare innovations and advancements worldwide. By actively engaging with its portfolio companies, often taking board positions and participating in follow-on financings or IPOs, HBM Healthcare Investments AG is deeply committed to the success and expansion of its investments.
HBM Healthcare Investments AG invests in venture capital funds as part of its fund of funds strategy, seeking to diversify its investment portfolio and tap into the broader potential within the healthcare sector. This approach allows HBM to access a wide range of healthcare-related ventures indirectly, spreading risks while participating in the growth of various companies.
The company is actively engaged in direct investments across different stages of a company's growth, including startup, early, mid, and late stages, as well as in mature companies. This direct involvement ranges from seed funding to support innovative healthcare solutions at their inception to providing growth capital and participating in buyouts and PIPES (Private Investment in Public Equity), accentuating HBM's flexibility and depth in investment strategies.
HBM Healthcare Investments AG primarily focuses its investments on the healthcare sector, with a special emphasis on human medicine, drugs, pharma, biopharma, biotechnology, diagnostics, medical technology, and related industries. This targeted approach allows HBM to leverage its extensive knowledge and experience in the healthcare sector, aiming to contribute to significant advancements in medical and health-related fields.
With a strategic focus on investing globally, particularly in the regions of Asia Pacific, Asia, North America, and Europe, HBM Healthcare Investments AG is dedicated to capturing the best healthcare investment opportunities across the world. This global perspective ensures that HBM can support healthcare innovations and companies based in different geographies, reflecting the universal need for healthcare advancements.
HBM Healthcare Investments AG primarily makes equity investments but also employs a variety of financial instruments to support its portfolio companies. These instruments might include convertible bonds, debt securities, structured products, and derivatives. This flexibility in investment tools underscores HBM's adaptability to different investment scenarios and its commitment to fostering company growth in the most effective manner possible.
The fund actively plans exit strategies for its investments, predominantly through trade sales or IPOs (Initial Public Offerings). By focusing on exit planning as a part of its investment strategy, HBM ensures that there is a clear path to realizing the value of its investments, thereby achieving returns for its investors and stakeholders.